Photo: EPA
According to the administration of the Buenos Aires province, a research done in Argentina found no significant adverse effects when the first component of the Russian coronavirus vaccine Sputnik V was combined with medicines from AstraZeneca and Sinopharm.
According to early findings from the current safety trial of mixing the Sputnik V vaccination with the medicines AstraZeneca and Sinopharm, no significant adverse effects have been found, according to the administration of the province of Buenos Aires, TASS reports.
The government has noted that following the second vaccine, 41.6 percent of study participants had not experienced any issues.
Per the …
